Daniele Salamone Email

Chief Financial Officer . CardioMech AS

Current Roles

Employees:
7
Revenue:
$1.7M
About
CardioMech is developing a catheter-based mitral valve repair technology designed to treat patients suffering from moderate to severe or severe, symptomatic DMR due to prolapse or flail. The CardioMech technology is designed to provide a catheter-based therapy for the placement of artificial chord(s) to reduce or eliminate MR as an alternative to surgical mitral valve repair. Caution: The CardioMech device is in the early R&D development phase and is NOT approved or cleared by the FDA or any other regulatory body in any region of the world. www.CardioMech.com
CardioMech AS Address
c/o Nikolai Hiorth Udbyes gate 3A 7030
Trondheim, -
CardioMech AS Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.